These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16866258)

  • 21. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT; Cherian S; Singh P
    Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of NSAID gastropathy: are neutrophils the culprits?
    Wallace JL; Granger DN
    Trends Pharmacol Sci; 1992 Apr; 13(4):129-31. PubMed ID: 1589904
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental NSAID-associated gastric mucosa injuries].
    Varvanina GG; Tkachenko EV; Drozdov VN; Trubitsyna IE
    Eksp Klin Gastroenterol; 2008; (6):34-5. PubMed ID: 19334425
    [No Abstract]   [Full Text] [Related]  

  • 24. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs.
    Helsper CW; Smeets HM; Numans ME; Knol MJ; Hoes AW; de Wit NJ
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):800-6. PubMed ID: 19572313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
    Chen JT; Pucino F; Resman-Targoff BH
    J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of NSAID-induced gastropathy.
    Zeidler H
    Clin Rheumatol; 1991 Dec; 10(4):369-73. PubMed ID: 1802489
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gastroduodenal erosive and ulcerous lesions induced by non-steroidal antiinflammatory drugs].
    Tsimmerman IaS; Tsimmerman IIa
    Klin Med (Mosk); 2008; 86(2):8-14. PubMed ID: 18368783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
    McColl KE
    Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
    Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
    Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
    Rostom A; Moayyedi P; Hunt R;
    Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [NSAID-induced gastropathy and its prophylaxis].
    Novikov VE; Kriukova NO; Krikova AV
    Eksp Klin Farmakol; 2008; 71(5):69-72. PubMed ID: 19093376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updates on the management of upper gastrointestinal disorders in the primary care setting: NSAID-related gastropathies and pediatric reflux diseases.
    Gold BD; Scheiman JM; Sabesin SM; Vitat P
    J Fam Pract; 2007 Mar; 56(3 Suppl Updates):S1-11; quiz S12. PubMed ID: 17343806
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case report on the clinical aspects and treatment of stomach ulcers caused by acute reserpine poisoning].
    Tashev T; Donev S
    Vutr Boles; 1987; 26(1):107-9. PubMed ID: 3590719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I need to take a nonsteroidal anti-inflammatory drug every day to control my arthritis. How can I decrease my chances of developing stomach troubles?
    Mayo Clin Health Lett; 2006 Nov; 24(11):8. PubMed ID: 17225264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.